Lorraine Little

Retired intensive care research project manager at ANZIC RC Monash University. #EPOTBI #TARGETtrial

[Lorraine Little @Research_ICU]

#TARGETTrial
@anzicrc @ANZICS_CTG @ClinResearchNZ
@sandrapeake01 #MarianneChapman
#LIVES2018

[NEJM @NEJM]

Original Article: Energy-Dense versus Routine Enteral Nutrition in the Critically Ill (TARGET) https://t.co/qdFCnzSC5L #LIVES2018

[Glenys Harrington @glenys_infexion]

Why are we getting a vaccine that has 66% efficacy when other vaccines have greater than 90% efficacy?
People in Australia will get AstraZeneca COVID-19 vaccine, Chief Medical Officer Paul Kelly says https://t.co/mvLbVZy1yv

[Prof Daryl Jones @jones_daza]

Please share.
Very proud to work with these nurses.
This is what our staff have to wear for up to 12 hours a day. Trust me, you do not want to meet them at work.
Please wear a mask

[NEJM @NEJM]

A randomized controlled trial testing dexamethasone for Covid-19 (the RECOVERY trial) showed that, compared with usual care, this corticosteroid drug reduced 28-day mortality in hospitalized patients. #COVID19 #SARSCoV2

[Samantha Bates @iamSam_au]

The @engunimelb team are amazing to work with. Couldn’t have had better expertise and support.

[Lorraine Little @Research_ICU]

@anzicrc @anzics @BellomoRinaldo
Another #EPOTBI publication

[Lorraine Little @Research_ICU]

EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial - ScienceDirect https://t.co/tXIAI9sMUP

[Lorraine Little @Research_ICU]

EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial - ScienceDirect https://t.co/tXIAI9sMUP

[Samantha Bates @iamSam_au]

For all my anaesthetic colleagues out there... I truly love you. But still laughing so hard as I tweet this 🤣 https://t.co/QCd4Zkvg0S

[remap-cap @remap_cap]

REMAP-CAP has responded to #COVID19 in a number of ways:
1. Activation of Pandemic strata
2. Modified CRF to collect relevant information on COVID-19
3. Additional sites and regions
4. Separate statistical model to drive response adaptive randomization for COVID-19 patients...

[Lorraine Little @Research_ICU]

@iwashyna Take care. Times are hard, thanks for what you do!

[Lorraine Little @Research_ICU]

@iwashyna You ok?

[Lorraine Little @Research_ICU]

@BobandAndySEN James Hird.

[Dr Kerryn Phelps AM @drkerrynphelps]

Time to stop this rubbish about #herdimmunity
Herd immunity is the desirable outcome of a national immunisation program.
It is NOT a strategy for preventing illness and death from an uncontrolled infectious disease.
There is no vaccine against #coronavirus yet

[9News Australia @9NewsAUS]

Supermarket giant @coles has announced a MAJOR recruitment drive - targeting 5000 new employees to help meet current demand. @tiffgenders #9News

[Court Network @CourtNetworkInc]

Domestic violence court support shut down https://t.co/Wst7moEZOY via @canberratimes

[Lorraine Little @Research_ICU]

1 year retirement anniversary today. I've had an amazing year. Part of my retirement gifts was an event of my choice...Max & I chose a day trip in Tuscany (Oct 2019). A beautiful memory.
Thank you @howe_belinda @anzicrc
#RetirementIsGreat

[TARGET Protein @ProteinTarget]

Want to hear the results of the TARGET Protein feasibility trial? Get registering before it’s too late!

[it’s the little things @ThinkitThruu]

@rosskenna352319

[Rinaldo Bellomo @BellomoRinaldo]

The VITAMINS trial has now been published in JAMA. Another great effort by ANZ and Brazilian investigators. A must read paper! https://t.co/oHCzJ2AzC3